Comparative in vitro activity of the new quinolone CI-934.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D002939:Ciprofloxacin; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects; D024841:Fluoroquinolones; D006193:Haemophilus influenzae / Q000187:drug effects; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D013291:Streptococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D010078:Oxazines; D011804:Quinolines; D002939:Ciprofloxacin; C047718:CI 934; D015242:Ofloxacin